Company Profile

Thermalin Inc
Profile last edited on: 3/17/21      CAGE: 7SBQ9      UEI: NZ8VXJXMMMW6

Business Identifier: Technologies for diabetes and insulin therapy
Year Founded
2010
First Award
2019
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

39 Karen Road
Waban, MA 02468
   (617) 938-3510
   info@thermalin.com
   www.thermalin.com
Location: Single
Congr. District: 04
County: Middlesex

Public Profile

Thermalin Inc develops new forms of insulin that aims to lower the burder of insulin use, increase patient adoption of and adherence to insulin therapy, improve patient lives and outcomes, and lowe the cost of caring for individuals with diabetes. The company has reformulated the insulin molecule to enable new delivery devices and systems. Some of the technologies the company is developing include Ultra Rapid insulin, insulin that does not require refrigeration, concentrated miniaturized pumps, an insulin patch, an oral solution, and glucose-responsive solutions.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Key People / Management

  Richard Berenson -- Founder, CEO

  Thomas Hattier -- Vice President of R&D

  Michael Dodson Michael -- Chief Scientific Officer

  Michael Weiss -- Founder & Chief Invention Officer

Company News

There are no news available.